High-throughput screening of human soluble epoxide hydrolase inhibitors.
- Author:
Shou-Bao WANG
1
;
Jing GUO
;
Xiao-Ming YU
;
Guan-Hua DU
Author Information
1. National Center for Pharmaceutical Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
- Publication Type:Journal Article
- MeSH:
Drug Evaluation, Preclinical;
methods;
Enzyme Inhibitors;
analysis;
chemistry;
Epoxide Hydrolases;
antagonists & inhibitors;
chemistry;
metabolism;
Escherichia coli;
metabolism;
High-Throughput Screening Assays;
methods;
Inhibitory Concentration 50;
Recombinant Proteins;
metabolism;
Reproducibility of Results;
Sensitivity and Specificity;
Spectrometry, Fluorescence;
methods;
Substrate Specificity
- From:
Acta Pharmaceutica Sinica
2010;45(11):1367-1372
- CountryChina
- Language:Chinese
-
Abstract:
To screen potential human soluble epoxide hydrolase (hsEH) inhibitors, a high-throughput screening model in 384-well microplate with total volume of 50 microL was established. Recombinant hsEH was cloned and expressed in E. coli. and its specific substrate PHOME was synthesized. The HTS model was based on fluorescence analysis with enhanced sensitivity and specificity (Z' = 0.65). A total of 47 360 samples (including 25 040 compounds and 22 320 natural products) were screened, of which 950 samples with inhibition greater than 80% were selected for further rescreening. Finally, two compounds with high inhibitory activity were identified, whose IC50 value were 8.56 and 4.31 micromol x L(-1), separately. The results indicated that the method was stable, sensitive, reproducible and also suitable for high-throughput screening.
